Clinical Trials
18 trialsNCT04923178 2026-06-05
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
National Institutes of Health Clinical Center (CC)
Recruiting
NCT03933826 2026-05-12
CISTO
University of Washington
Active not recruiting
NCT04354064 2026-02-20
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Washington University School of Medicine
Recruiting
NCT06724159 2026-02-17
SOGUG-PRINCIS
Spanish Oncology Genito-Urinary Group
Recruiting
NCT04501913 2025-12-05
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes
City of Hope Medical Center
Completed
NCT06676527 2025-12-05
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
Recruiting
NCT05649306 2025-10-03
Gender Related Coping and Survivorship for Genitourinary Cancers
Johns Hopkins University
Recruiting
NCT05887245 2025-06-27
Clinical Significance of Adherent Perinephric Fat in Patients Undergoing Partial Nephrectomy
Centre of Postgraduate Medical Education
Active not recruiting
NCT04578132 2025-04-01
SOGUGCOVID
Spanish Oncology Genito-Urinary Group
Completed
NCT05874921 2025-02-28
uTRACT
UroGen Pharma Ltd.
Recruiting
NCT04761107 2025-01-31
Impact of COVID-19 on GU Disease
Icahn School of Medicine at Mount Sinai
Active not recruiting
NCT04005183 2024-10-10
REMEDY
University Health Network, Toronto
Completed
NCT03134027 2024-07-18
Immune PDX
Duke University
Terminated
NCT01398306 2024-05-06
BANN
University Medical Center Groningen
Completed
NCT03099031 2019-12-16
PREDICARE
LEO Pharma
Completed
NCT01339975 2019-08-05
ChemoRenCan
University Hospital, Bordeaux
Completed
NCT01441661 2013-03-18
Sunitinib Intake Conditions in the Treatment of Patients With Renal Cell Carcinoma
Cancer Foundation, China
Completed
NCT00460798 2010-11-16
SUNIKA
Pfizer
Completed